[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"standardized-implementation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:standardized-implementation":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100620874","standardized-implementation-and-quality-assessment-system-for-confocal-enteroscopy-100620874",false,"NCT07363291","Standardized Implementation and Quality Assessment System for Confocal Enteroscopy","Inclusion Criteria:\n\n* Aged 18-70 years and scheduled to undergo small-bowel endoscopy.\n* Able to provide written informed consent and willing to participate in the study.\n* Certified gastroenterologists with an intermediate (or higher) professional title.\n\nHave completed formal training and passed competency assessments in gastroscopy, colonoscopy, and small-bowel endoscopy.\n\n-Willing to participate and able to provide written informed consent.\n\nExclusion Criteria:\n\n* Poor general condition, severe hepatic or renal insufficiency, or inability to tolerate complete endoscopic examination.\n* Known hypersensitivity to any study-related agents (fluorescein sodium, polyethylene glycol, lidocaine mucilage).\n* Currently enrolled in another clinical trial.\n* Never perform endoscopic procedures.\n* Endoscopic procedure or image-reading volume \\\u003C 100 cases in the past 2 years.\n* Medical license revoked or currently suspended for any reason.","ALL","18 Years","70 Years",{"count":19,"type":20},600,"ESTIMATED","3 Years","OBSERVATIONAL","Confocal technology, hailed as \"optical biopsy,\" enables real-time cellular-level histological examination of mucosal surfaces. Its integration with double-balloon enteroscopy significantly enhances the clinical feasibility of targeted biopsy, early diagnosis, and endoscopic staging for small bowel diseases such as inflammatory bowel disease. Currently, confocal endoscopy is primarily applied to upper and lower gastrointestinal tract diseases, leaving small bowel pathologies largely unexplored. Consequently, establishing a diagnostic framework for small bowel tumors and non-neoplastic lesions using confocal enteroscopy, alongside developing quality assessment standards for its operational procedures, is of paramount importance.",[25,26,27],"Confocal Enteroscopy","Quality Assessment System","Standardized Implementation",[25,27,26],"RECRUITING","2026-01-15",{"date":32,"type":33},"2026-01-23","ACTUAL",{"date":35,"type":33},"2025-06-01",{"date":37,"type":20},"2028-06-01",{"name":39,"class":40},"Shanghai Jiao Tong University School of Medicine","OTHER",8]